October 2026
Vol. 1 | No. 1
From the editor
Both articles in this first issue start from the same place: something you can buy today, backed by a claim that sounds like science. Peptides promise faster healing and slower aging; ultra-processed food is said to be quietly damaging our brains. In each case the headlines run well ahead of the studies, and the studies themselves are a mix of strong trials, small pilots and work that has never left the lab. The point of The Abyss is to sort one from the other, plainly, with every claim traced back to its source, so that the next time one of these stories crosses your feed you know how much weight it can bear.
Table of contents
About the cover
Crystals of insulin, the first peptide to become a medicine and the standard against which the peptides in this issue’s Evidence Check are measured. A new kind of insulin can modify its activity in response to glucose levels in the blood. Credit: Antonio Romero / Science Photo Library.